User: Guest  Login
If you experience problems opening the document, please try this link.
Document type:
Zeitschriftenaufsatz
Author(s):
Fizazi, Karim ; Retz, Margitta ; Petrylak, Daniel P ; Goh, Jeffrey C ; Perez-Gracia, Jose ; Lacombe, Louis ; Zschäbitz, Stefanie ; Burotto, Mauricio ; Mahammedi, Hakim ; Gravis, Gwenaelle ; Bastos, Diogo Assed ; McCune, Steven L ; Vázquez Limón, Juan Carlos ; Kwan, Edmond M ; Castellano, Daniel ; Fléchon, Aude ; Saad, Fred ; Grimm, Marc-Oliver ; Shaffer, David R ; Armstrong, Andrew J ; Bhagavatheeswaran, Prabhu ; Amin, Neha P ; Ünsal-Kaçmaz, Keziban ; Wang, Xuya ; Li, Jun...     »
Title:
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
Keywords:
Clinical/translational cancer immunotherapy ; Clinical Trials, Phase II as Topic ; Immunotherapy
Journal title:
Journal for ImmunoTherapy of Cancer
Year:
2022
Journal volume:
10
Journal issue:
8
Fulltext / DOI:
doi:10.1136/jitc-2022-004761
Publisher:
BMJ Publishing Group Ltd
E-ISSN:
2051-1426
Date of publication:
17.08.2022
 BibTeX